Hepatitis, cirrhosis, and hepatoma

Journal of Magnetic Resonance Imaging

Volumn 8, Issue 2, 1998, Pages 346-358

  Murakami, Takamichi ^a,b   Kim, Tonsok ^b   Nakamura, Hironobu ^b  

^a TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cirrhosis; Hepatitis; Liver; Liver, disease; Liver, ME; Myer, neoplasms

Indexed keywords

ARTIFICIAL EMBOLISM; CELL INFILTRATION; DIAGNOSTIC IMAGING; HEPATITIS; HUMAN; IMAGE RECONSTRUCTION; INFLAMMATORY CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HEPATITIS, CHRONIC; HUMANS; JAPAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031922680     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880080214     Document Type: Review

References (49)

1. Ohno E, Omata E. Pathological evaluation of hepatitis C and its clinical meaning. Medical Practice 1996; 13:1332-1337 [in Japanese].
2. Kawasaki H, Murawaki Y. The basics of diagnosis of liver cirrhosis. Medicina 1992; 29:1524-1527 [in Japanese].
3. Kaneko S, Kobayashi K. Hepatocellular carcinoma: risk of onset and clinical measures against it. Medical Practice 1996; 13: 1338-1343 [in Japanese].
4. Kobayashi K, Hattori N. Early screening of hepatocellular carcinoma. J Med Imaging 1990; 18-25.
5. Stark DD, Bass NM, Moss AA, et al. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 1983; 148:743-751.
6. Murakami T, Baron RL, Peterson MS. Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. Radiology 1996; 198:239-242.
7. Itai Y, Ohtomo K, Kokubo T, Minami N, Yoshida H. CT and MR images of postnecrotic liver scars. J Comput Assist Tomogr 1988; 12:971-975.
8. Popper H. Pathologic aspects of cirrhosis: a review. Am J Pathol 1977; 87:228-264.
9. Harbin WP, Robert NJ, Ferrucci J Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 1980; 135:273-283.
10. Ohtomo K, Baron RL, Dodd GD III, et al. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188:31-35.
11. Ohtomo K, Baron RL, Dodd GD III, Federle MP, Ohtomo Y, Confer SR. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189:871-874.
12. Murakami T, Kuroda C, Marukawa T, et al. Regenerating nodules of hepatic cirrhosis; MR findings with pathologic correlation. Am J Roentgenol 1990; 155:1227-1231.
13. Ohtomo K, Itai Y, Ohtomo Y, Shiga J, Ito M. Regeneration nodules of liver cirrhosis: MR imaging with pathologic correlation. Am J Roentgenol 1990; 154:505-507.
14. Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 198:567-572.
15. Murakami T, Nakamura H, Hori S, et al. CT and MRI of siderotic regenerating nodules in cirrhotic liver. J Comput Assist Tomogr 1992; 16:578-582.
16. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histologic findings. Radiology 1992; 183:819-825.
17. Minami M, Itai Y, Ohtomo K, et al. Siderotic nodules in the spleen; MR imaging of portal hypertension. Radiology 1989; 172:681-684.
18. Le Behan D, Breton E, Lallemand D, Aubin ML, Vigaud J, Laval Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
19. Tsuda K, Murakami T, Sakurai K, et al. Preliminary evaluation of the apparent diffusion coefficient of the kidney with a spiral IVIM sequence. Nippon ACTA Radiol 1997; 57:19-22.
20. Muller MF, Prasad P, Siewert B, Missenbaum MA, Raptopoulos V, Edelman RR. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994; 190: 475-478.
21. Muller MF, Prasad PV, Bimmler D, Kaiser A, Edelman RR. Functional imaging of the kidney by means of measurement of the apparent diffusion coefficient. Radiology 1994; 193:711-715.
22. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168:297-301.
23. Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC. Hepatobiliary MR imaging: first human experience with MnDPDP. Radiology 1991; 178:79-82.
24. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195:785-792.
25. Kim T, Murakami T, Hasuike Y, et al. Experimental hepatic dysfunction: evaluation by MR imaging with Gd-EOB-DTPA. JMRI 1997; 7:683-688.
26. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. Tokyo: Kanehara, 1992; 14-17.
27. Kim T, Murakami T, Oi H, et al. Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 1995; 19:948-954.
28. Mitsuzaki K, Yamashita Y, Ogata I, Nishiharu T, Urata J, Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrastinjection protocol and optimal timing. Am J Roentgenol 1996; 167:753-757.
29. Nishikawa J, Itai Y, Tasaka A. Lobar attenuation difference of the liver on computed tomography. Radiology 1981; 141:725-728.
30. Itai Y, Ohtomo K, Furui S, Minami M, Yoshikawa K, Yashiro N. Lobar intensity differences of the liver on MR imaging. J Comput Assist Tomogr 1986; 10:236-241.
31. Murakami T, Mitani T, Nakamura H, et al. Differentiation between hepatoma and hemangioma with inversion recovery snapshot FLASH MRI and Gd-DTPA. J Comput Assist Tomogr 1992; 16:198-205.
32. Nakamura H, Murakami T, Ishida T, et al. 3DFT-FISP MRI with gadopentetate dimeglumine in differential diagnosis of small liver tumor. J Comput Assist Tomogr 1994; 18:49-54.
33. Murakami T, Nakamura H, Tsuda K, et al. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Am J Roentgenol 1993; 160:295-299.
34. Murakami T, Nakamura H, Hori S, et al. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil: pathologic correlation with dynamic turbo-FLASH MR imaging. Acta Radiol 1993; 34:399-403.
35. Araki T, Ital Y, Furui S, Tasaka A. Dynamic CT densitometry of hepatic tumors. Am J Roentgenol 1980; 135:1037-1043.
36. Ohashi I, Hanafusa K, Yoshida T. Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. Radiology 1993; 189:851-855.
37. Hori M, Murakami T, Oi H, et al. Sensitivity of hepatocellular carcinoma detection by helical CT with intraarterial injection, and by helical CT and MR imaging with intravenous injection of contrast medium. Acta Radiol 1998 (in press).
38. Mitani T, Nakamura H, Murakami T, et al. Dynamic MR studies of hepatocellular carcinoma with portal vein tumor thrombosis. Radiat Med 1992; 10:232-234.
39. Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989; 170:783-786.
40. Sironi S, Livraghi T, Angeli E, et al. Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection. Radiology 1993; 187:119-123.
41. Nagel HS, Bernardino ME. Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy. Radiology 1993; 189:265-270.
42. Ito K, Honjo K, Fujita K, Awaya H, Matsumoto T, Matsunaga N. Enhanced MR imaging of the liver after ethanol treatment of hepatocellular carcinoma: evaluation of areas of hyperperfusion adjacent to the tumor. Am J Roentgenol 1995; 164:1413-1417.
43. Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 200:69-77.
44. Ishida T, Murakami T, Kato N, et al. Superparamagnetic iron oxide enhanced MR imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule. Invest Radiol 1997; 32: 282-287.
45. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198:881-887.
46. Matsui O, Kadoya M, Kameyama T, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989; 173: 123-126.
47. Winter TC III, Takayasu K, Muramatsu Y, et al. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 1994; 192:379-387.
48. McFarland EG, Mayo-Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 1994; 193:43-47.
49. Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG. Hepatic lesions: discrimination of non solid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 1997; 204:729-737.